Read Research Alzheimer's More' title='Share this by email.' class='social email'>           

Multiple BACE1 inhibitors abnormally increase the BACE1 protein level in neurons by prolonging its half-life

There is keen interest in elucidating the biological mechanisms underlying recent failures of β-site amyloid precursor protein–cleaving enzyme-1 (BACE1) inhibitors in Alzheimer’s disease trials. Read & Research Alzheimer’s More

Leave a Reply